Close
Corporate Laboratory

[email protected]

[email protected] Corporate Laboratory is a research partnership between the National University of Singapore and Wilmar International Limited and is hosted at the Yong Loo Lin School of Medicine, NUS.

About UsTeam

About

We Create Awesome Stuff

[email protected] Corporate Laboratory is a research partnership between the National University of Singapore and Wilmar International Limited and is hosted at the Yong Loo Lin School of Medicine, NUS.

Founded in 1991 and headquartered in Singapore, Wilmar International Limited is a global leader in the manufacturing and processing of food ingredients, particularly oleochemicals. As Asia’s preeminent agribusiness group, its extensive business activities include oil palm cultivation, edible oils refining, specialty fats and oleochemicals production, sugar milling and refining, flour and rice milling as well as biodiesel and fertilizer production. Besides having an integrated agribusiness model that oversees the cultivation, processing, merchandising and manufacturing of a wide range of agricultural commodities, Wilmar also conducts R&D in numerous countries including Singapore, China and Indonesia.

As one of Asia’s leading university, NUS is recognized for its breadth of academic programmes and impactful research. Taking an integrated and multidisciplinary approach to research, NUS works with partners from industry, government and academia to address crucial real-world issues. A key hub for health and biomedical sciences research with a focus on Asian populations, NUS has strong capabilities in food and nutritional sciences as well as translational medicine.

[email protected] Corporate Laboratory aims to leverage the expertise of Wilmar and NUS to:

Identify Ingredients

Identify food ingredients and food components capable of modulating glycemic control, lowering triglycerides and cholesterol as well as aid in healthy ageing.

Develop Methods

Develop efficient and cost-effective, bio-based methods for the production of industrial enzymes and biochemicals.

Safety Declaration

Declaration of Commitment to Safety

I am dedicated to make Safety a priority and will adhere to the established safety practices and requirements. I am committed to upholding the highest standards of occupational safety and health in the workplace.

Team

Who We Are

Our success depends on the strength of our team.

Prof Chua Nam Hai

Investigator, [email protected]
Chief Scientific Advisor, Wilmar

Prof Jeyakumar Henry

Investigator, [email protected]
Director, CNRC

Prof Chong Yap Seng

Investigator, [email protected]
Dean, NUSMedicine

Assoc Prof Matthew Chang

Director, [email protected]
Director, NUS SynCTI

Assoc Prof Yew Wen Shan

Investigator, [email protected]
Deputy Director, NUS SynCTI

Dr Ng Kian Hong

[email protected] Acting Co-Lab Director (Admin)

Dr Untzizu Ochandiano Elejalde

[email protected] Acting Co-Lab Director (Admin)

We want to change
peoples lives

[email protected] will develop Food as the New Medicine that will enhance the health and well-being of consumers, especially Asians. Such food include blended cooking oils that can reduce hyperlipidaemia and possibly, hypertension and insomnia in the elderly; a functional food drink that can prevent sarcopenia; as well as food products, such as ready-to-eat meals and drinks, for weight management and control of blood glucose and lipids.

Who We Are

[email protected] will give rise to research outcomes with impact that are far-reaching and cut across many industry sectors.

WIL is a global leader in the processing and merchandising of food ingredients and food products and it is also a world-leading oleochemicals company. NUS is a globally leading university, with deep expertise in health and biomedical sciences research, including in the areas of ageing, biomedical sciences and translational medicine, and engineering of microbes to produce enzymes and biochemicals.

Research

Our Projects


In Asia, rapid urbanisation has led to changing diets, often adversely affecting health across communities. In recent years, there is growing interest on the incidence, progression and treatment of diseases in Asian populations and how the region’s dietary preferences and food culture influence health and well-being. Besides facing increasing incidence of obesity, diabetes and cardiovascular diseases, Singapore is also confronted with an ageing population, impelling the need to seek innovative solutions expressly in the synergy between food and medicine.

At the same time, there is a demand in the food and pharmaceutical industries for environmentally sustainable bio-based methods for the production of industrial enzymes and specialty biochemicals, ushering in the potential use of microbial platforms to meet the techno-economic needs of the industry.

Contact

Keep In Touch

Tel.: +65 6601 5419

National University of Singapore,
Centre for Translational Medicine,
MD6, 14 Medical Drive, #10-01,
Singapore, 117599

[email protected]
WWW.WIL-NUS.SG